Package 72516-017-06

{"route": ["ORAL"], "spl_id": "461d8570-9132-90a2-e063-6294a90abb5a", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "upc": ["0372516017064"], "unii": ["GLH0314RVC"], "rxcui": ["1666332"], "spl_set_id": ["461d810e-5b77-5e53-e063-6294a90a64b0"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Oryza Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (72516-017-06)", "package_ndc": "72516-017-06", "marketing_start_date": "20251201"}], "brand_name": "Ticagrelor", "product_id": "72516-017_461d8570-9132-90a2-e063-6294a90abb5a", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "72516-017", "generic_name": "Ticagrelor", "labeler_name": "Oryza Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ticagrelor", "active_ingredients": [{"name": "TICAGRELOR", "strength": "60 mg/1"}], "application_number": "ANDA208508", "marketing_category": "ANDA", "marketing_start_date": "20251201", "listing_expiration_date": "20261231"}